{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:51:39Z","timestamp":1771019499935,"version":"3.50.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cca.2022.06.019","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:44:48Z","timestamp":1655433888000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Circulating microparticles as indicators of cardiometabolic risk in PCOS"],"prefix":"10.1016","volume":"533","author":[{"given":"Banafsheh","family":"Yalameha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Nejabati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2022.06.019_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fendo.2020.00516","article-title":"Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions","volume":"11","author":"Aversa","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2022.06.019_b0015","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.cca.2022.06.019_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mce.2017.01.017","article-title":"Microparticles: inflammatory and haemostatic biomarkers in polycystic ovary syndrome","volume":"443","author":"Carvalho","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0025","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.18632\/oncotarget.23985","article-title":"Coronary artery disease risk in young women with polycystic ovary syndrome","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.cca.2022.06.019_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17446651.2019.1556094","article-title":"Cardiometabolic risks in PCOS: a review of the current state of knowledge","volume":"14","author":"Kakoly","year":"2019","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0035","doi-asserted-by":"crossref","first-page":"33715","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.cca.2022.06.019_b0040","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-15-0201","article-title":"Microvesicles and exosomes: new players in metabolic and cardiovascular disease","volume":"228","author":"Lawson","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0045","first-page":"968","article-title":"Extracellular vesicles: recent developments in aging and reproductive diseases","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2022.06.019_b0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jvim.12128","article-title":"Microparticles in health and disease","volume":"27","author":"Herring","year":"2013","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s42000-020-00182-1","article-title":"Oral contraceptives increase platelet microparticle concentrations in normal-weight women with polycystic ovary syndrome","volume":"19","author":"Papadakis","year":"2020","journal-title":"Hormones"},{"key":"10.1016\/j.cca.2022.06.019_b0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-019-02059-9","article-title":"The CD105: CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects","volume":"66","author":"Al-Qaissi","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2022.06.019_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-11-0144","article-title":"Circulating platelet-derived microparticles are increased in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone concentrations","volume":"165","author":"Koiou","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am. J. Obs. Gynecol."},{"key":"10.1016\/j.cca.2022.06.019_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2478\/enr-2018-0026","article-title":"Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review","volume":"52","author":"Carvalho","year":"2018","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.cca.2022.06.019_b0080","article-title":"New diagnosis of polycystic ovary syndrome","volume":"356","author":"McLuskie","year":"2017","journal-title":"BMJ Br. Med. J."},{"key":"10.1016\/j.cca.2022.06.019_b0085","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/nu13051677","article-title":"Natural molecules in the management of Polycystic Ovary Syndrome (PCOS): an analytical review","volume":"13","author":"Iervolino","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.cca.2022.06.019_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int. J. Womens. Health."},{"key":"10.1016\/j.cca.2022.06.019_b0100","doi-asserted-by":"crossref","unstructured":"H. Liu, H. Zhao, Z.-J. Chen, Genome-wide association studies for polycystic ovary syndrome, in: Semin. Reprod. Med., Thieme Medical Publishers, 2016, pp. 224\u2013229.","DOI":"10.1055\/s-0036-1585403"},{"key":"10.1016\/j.cca.2022.06.019_b0105","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0110","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/jwh.2018.7162","article-title":"Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome?","volume":"27","author":"Carmina","year":"2018","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.cca.2022.06.019_b0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000455233","article-title":"Cardiometabolic risks in polycystic ovary syndrome: non-traditional risk factors and the impact of obesity","volume":"104","author":"Chiu","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cca.2022.06.019_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000341838","article-title":"Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome","volume":"40","author":"Studen","year":"2013","journal-title":"Polycystic Ovary Syndr."},{"key":"10.1016\/j.cca.2022.06.019_b0125","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2022.06.019_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2009.03.005","article-title":"Can serum apolipoprotein CI demonstrate metabolic abnormality early in women with polycystic ovary syndrome?","volume":"94","author":"Huang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2022.06.019_b0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","journal-title":"Taiwan. J Obstet. Gynecol."},{"key":"10.1016\/j.cca.2022.06.019_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000341683","article-title":"Dyslipidemia and oxidative stress in PCOS","volume":"40","author":"Macut","year":"2013","journal-title":"Polycystic Ovary Syndr."},{"key":"10.1016\/j.cca.2022.06.019_b0150","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/ijms12053117","article-title":"Inflammation, oxidative stress, and obesity","volume":"12","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2022.06.019_b0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-014-0428-x","article-title":"Alterations in cardiac structure and function in hypertension","volume":"16","author":"Santos","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cca.2022.06.019_b0165","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1097\/HJH.0b013e3283630362","article-title":"Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype","volume":"31","author":"Armeni","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2022.06.019_b0170","first-page":"154","article-title":"Higher blood pressure in normal weight women with PCOS compared to controls, Endocr","volume":"10","author":"Mellembakken","year":"2021","journal-title":"Connect."},{"key":"10.1016\/j.cca.2022.06.019_b0175","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/EJE-16-0373","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome","volume":"176","author":"Glintborg","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10641963.2020.1772815","article-title":"Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)","volume":"42","author":"\u00d6zkan","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.cca.2022.06.019_b0185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2022.06.019_b0190","doi-asserted-by":"crossref","unstructured":"M.-M.E. Ollila, K. Kaikkonen, M.-R. J\u00e4rvelin, H. V Huikuri, J.S. Tapanainen, S. Franks, T.T. Piltonen, L. Morin-Papunen, Self-reported polycystic ovary syndrome is associated with hypertension: a northern Finland birth cohort 1966 study, J. Clin. Endocrinol. Metab. 104 (2019) 1221\u20131231.","DOI":"10.1210\/jc.2018-00570"},{"key":"10.1016\/j.cca.2022.06.019_b0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2017.10.018","article-title":"Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"109","author":"Yilmaz","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2022.06.019_b0200","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7861\/clinmedicine.16-3-262","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"16","author":"Barber","year":"2016","journal-title":"Clin. Med. (Northfield. Il)."},{"key":"10.1016\/j.cca.2022.06.019_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review","volume":"13","author":"Livadas","year":"2022","journal-title":"World J. Diabetes."},{"key":"10.1016\/j.cca.2022.06.019_b0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2022.06.019_b0215","article-title":"Association of androgen excess with glucose intolerance in women with polycystic ovary syndrome","volume":"2018","author":"Zhang","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2022.06.019_b0220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2022.06.019_b0225","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/jcmm.16205","article-title":"The role of androgen and its related signals in PCOS","volume":"25","author":"Ye","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum. Reprod. Update."},{"key":"10.1016\/j.cca.2022.06.019_b0235","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/etm.2017.4642","article-title":"Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy","volume":"14","author":"Yao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/09513590.2015.1101438","article-title":"The effects of polycystic ovary syndrome on gestational diabetes mellitus","volume":"32","author":"Aktun","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140544","article-title":"Relationship between polycystic ovarian syndrome and subsequent gestational diabetes mellitus: a nationwide population-based study","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2022.06.019_b0250","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/aogs.13883","article-title":"Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: A follow-up cohort study","volume":"99","author":"West","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.cca.2022.06.019_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-019-0462-6","article-title":"Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study","volume":"11","author":"Zheng","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2022.06.019_b0260","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cen.14421","article-title":"Obesity and polycystic ovary syndrome","volume":"95","author":"Barber","year":"2021","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.cca.2022.06.019_b0265","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/01443615.2017.1318840","article-title":"Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis","volume":"37","author":"Li","year":"2017","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"key":"10.1016\/j.cca.2022.06.019_b0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719114561552","article-title":"Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation","volume":"22","author":"Schulte","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.cca.2022.06.019_b0275","doi-asserted-by":"crossref","unstructured":"I.E. Messinis, C.I. Messini, K. Dafopoulos, Obesity in polycystic ovary syndrome and infertility, in: Obes. Gynecol., Elsevier, 2020: pp. 23\u201334.","DOI":"10.1016\/B978-0-12-817919-2.00003-6"},{"key":"10.1016\/j.cca.2022.06.019_b0280","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/786362","article-title":"Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women","volume":"2015","author":"Baldani","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.cca.2022.06.019_b0290","doi-asserted-by":"crossref","unstructured":"A. Dokras, Cardiovascular disease risk factors in polycystic ovary syndrome, in: Semin. Reprod. Med., \u00a9 Thieme Medical Publishers, 2008, pp. 39\u201344.","DOI":"10.1055\/s-2007-992923"},{"key":"10.1016\/j.cca.2022.06.019_b0295","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.4049\/jimmunol.1002788","article-title":"Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells","volume":"186","author":"Sadallah","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2022.06.019_b0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2022.06.019_b0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CS20120309","article-title":"Microparticles: biomarkers and beyond","volume":"124","author":"Burger","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cca.2022.06.019_b0310","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/bmm-2015-0063","article-title":"Microparticles as biomarkers of venous thromboembolic events","volume":"10","author":"Campello","year":"2016","journal-title":"Biomark. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0315","doi-asserted-by":"crossref","first-page":"L364","DOI":"10.1152\/ajplung.00354.2011","article-title":"Microparticles and acute lung injury","volume":"303","author":"McVey","year":"2012","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.cca.2022.06.019_b0320","doi-asserted-by":"crossref","unstructured":"R. Flaumenhaft, A.T.A. Mairuhu, J.E. Italiano, Platelet-and megakaryocyte-derived microparticles, in: Semin. Thromb. Hemost., \u00a9 Thieme Medical Publishers, 2010, pp. 881\u2013887.","DOI":"10.1055\/s-0030-1267042"},{"key":"10.1016\/j.cca.2022.06.019_b0325","first-page":"527","article-title":"Microparticles in sputum of COPD patients: a potential biomarker of the disease?","volume":"11","author":"Lacedonia","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.cca.2022.06.019_b0330","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/HYPERTENSIONAHA.121.16975","article-title":"Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation","volume":"77","author":"Lugo-Gavidia","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2022.06.019_b0335","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOH.0b013e32833e77ee","article-title":"Clinical relevance of microparticles from platelets and megakaryocytes","volume":"17","author":"Italiano","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2022.06.019_b0340","doi-asserted-by":"crossref","unstructured":"B. Ed Nignpense, K.A. Chinkwo, C.L. Blanchard, A.B. Santhakumar, Polyphenols: modulators of platelet function and platelet microparticle generation?, Int. J. Mol. Sci. 21 (2019) 146.","DOI":"10.3390\/ijms21010146"},{"key":"10.1016\/j.cca.2022.06.019_b0345","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/jcmm.13125","article-title":"Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review","volume":"21","author":"Deng","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.110.218123","article-title":"The many faces of endothelial microparticles","volume":"31","author":"Dignat-George","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2022.06.019_b0355","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00441-008-0710-9","article-title":"Endothelial microparticles in diseases","volume":"335","author":"Chironi","year":"2009","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cca.2022.06.019_b0360","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cca.2022.06.019_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-016-0087-4","article-title":"Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later","volume":"5","author":"Ratajczak","year":"2016","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.20452\/pamw.1489","article-title":"Microparticles: a component of various diseases","volume":"122","author":"Budaj","year":"2012","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.cca.2022.06.019_b0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04773.x","article-title":"Platelet microparticles induce angiogenesis in vitro","volume":"124","author":"Kim","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2022.06.019_b0380","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1002\/jcp.28499","article-title":"Circulating microparticles as biomarkers of stroke: a focus on the value of endothelial-and platelet-derived microparticles","volume":"234","author":"El-Gamal","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2022.06.019_b0385","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1007\/s13277-016-5358-6","article-title":"The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression","volume":"37","author":"\u017bmigrodzka","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cca.2022.06.019_b0390","article-title":"Circulating endothelial microparticles: a key hallmark of atherosclerosis progression","volume":"2016","author":"Paudel","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.cca.2022.06.019_b0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1183\/16000617.0009-2016","article-title":"Cell-derived microparticles and the lung","volume":"25","author":"Nieri","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.cca.2022.06.019_b0400","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.thromres.2014.12.006","article-title":"Increased circulating VE-cadherin+ CD144+ endothelial microparticles in ischemic cerebrovascular disease","volume":"135","author":"Li","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2022.06.019_b0405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jalz.2014.06.003","article-title":"Increased cerebrospinal fluid calpain activity and microparticle concentrations in Alzheimer\u2019s disease","volume":"11","author":"Laske","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.cca.2022.06.019_b0410","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1160\/TH10-11-0712","article-title":"Involvement of microparticles in diabetic vascular complications","volume":"106","author":"Tsimerman","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2022.06.019_b0415","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fimmu.2018.00322","article-title":"Potential involvement of platelet-derived microparticles and microparticles forming immune complexes during monocyte activation in patients with systemic lupus erythematosus","volume":"9","author":"Burbano","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2022.06.019_b0420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fphar.2019.00007","article-title":"Platelet-derived microparticles from obese individuals: characterization of number, size, proteomics, and crosstalk with cancer and endothelial cells","author":"Grande","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2022.06.019_b0425","doi-asserted-by":"crossref","unstructured":"K.F. Rodrigues, N.T. Pietrani, A.P. Fernandes, A.A. Bosco, M.C.R. de Sousa, I. de F.O. Silva, J.N. Silveira, F.M.F. Campos, K.B. Gomes, Circulating microparticles concentrations are increased in patients with diabetic kidney disease: A case-control research, Clin. Chim. Acta. 479 (2018) 48\u201355.","DOI":"10.1016\/j.cca.2017.12.048"},{"key":"10.1016\/j.cca.2022.06.019_b0430","first-page":"485","article-title":"Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers, Diabetes","volume":"12","author":"Zahran","year":"2019","journal-title":"Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.cca.2022.06.019_b0435","first-page":"1","article-title":"CD36+\/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor","author":"Zhou","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.cca.2022.06.019_b0440","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.06.018","article-title":"The role of circulating platelets microparticles and platelet parameters in acute ischemic stroke patients","volume":"24","author":"Chen","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.cca.2022.06.019_b0445","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","article-title":"Platelet-derived microvesicles in cardiovascular diseases","volume":"4","author":"Zaldivia","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-020-00841-z","article-title":"Microparticles (exosomes) and atherosclerosis","volume":"22","author":"Chen","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cca.2022.06.019_b0455","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/SHK.0000000000001309","article-title":"Protein compositions changes of circulating microparticles in patients with valvular heart disease subjected to cardiac surgery contribute to systemic inflammatory response and disorder of coagulation","volume":"52","author":"Jian","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.cca.2022.06.019_b0460","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1160\/TH11-11-0779","article-title":"Platelet-derived microparticles during and after acute coronary syndrome","volume":"107","author":"Skeppholm","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cca.2022.06.019_b0465","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12265-019-09945-7","article-title":"The level of circulating microparticles in patients with coronary heart disease: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.cca.2022.06.019_b0470","doi-asserted-by":"crossref","unstructured":"X.-Y. Geng, N. Xiao, Y. Han, Y.-J. Li, Platelet microparticles: a tool to predict infarction area in rats, J. Investig. Surg. (2019).","DOI":"10.1080\/08941939.2019.1606369"},{"key":"10.1016\/j.cca.2022.06.019_b0475","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/humrep\/deu281","article-title":"Young women with polycystic ovary syndrome have raised concentrations of circulating annexin V-positive platelet microparticles","volume":"29","author":"Willis","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cca.2022.06.019_b0480","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40618-015-0273-z","article-title":"Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus","volume":"38","author":"Berezin","year":"2015","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cca.2022.06.019_b0485","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1515\/cclm-2015-0605","article-title":"Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure","volume":"54","author":"Berezin","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","article-title":"The role of MiRNA in polycystic ovary syndrome (PCOS)","volume":"706","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.cca.2022.06.019_b0495","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10815-013-0161-4","article-title":"Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome","volume":"31","author":"Roth","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.cca.2022.06.019_b0500","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2020.08.019","article-title":"Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome","volume":"115","author":"Jiang","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2022.06.019_b0505","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","article-title":"Cardiovascular disease risk in women with PCOS","volume":"78","author":"Dokras","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.cca.2022.06.019_b0510","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/09513590903159565","article-title":"Association of polycystic ovary syndrome with cardiovascular risk factors","volume":"26","author":"Akram","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0515","first-page":"1325","article-title":"Higher plasma concentrations of platelet microparticles in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"32","author":"Sun","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cca.2022.06.019_b0520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2005.12.013","article-title":"Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity","volume":"119","author":"Murakami","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cca.2022.06.019_b0525","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2006-0851","article-title":"Endothelial microparticles correlate with endothelial dysfunction in obese women","volume":"91","author":"Esposito","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0530","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/09513590.2012.743005","article-title":"Platelet-derived microparticles in overweight\/obese women with the polycystic ovary syndrome","volume":"29","author":"Koiou","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0535","first-page":"313","article-title":"Chronic inflammation in polycystic ovary syndrome: A case\u2013control study using multiple markers","volume":"19","author":"Goswami","year":"2021","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.cca.2022.06.019_b0540","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000494908","article-title":"Obesity and androgens in women","volume":"53","author":"Pasquali","year":"2019","journal-title":"Hyperandrogenism in Women."},{"key":"10.1016\/j.cca.2022.06.019_b0545","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2022.06.019_b0550","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0555","first-page":"2693","article-title":"Oxidized LDL activates blood platelets through CD36\/NOX2\u2013mediated inhibition of the cGMP\/protein kinase G signaling cascade, Blood","volume":"125","author":"Magwenzi","year":"2015","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.cca.2022.06.019_b0560","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/ATVBAHA.111.244707","article-title":"Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo\u2014brief report","volume":"32","author":"Stellos","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2022.06.019_b0565","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/jc.2016-1858","article-title":"Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial","volume":"101","author":"Banaszewska","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2022.06.019_b0570","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2019.06.009","article-title":"Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS)","volume":"671","author":"Atef","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2022.06.019_b0575","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/09513590.2018.1490405","article-title":"Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome","volume":"34","author":"Seyam","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cca.2022.06.019_b0580","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00404-017-4471-0","article-title":"Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome","volume":"296","author":"Carvalho","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.cca.2022.06.019_b0585","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1479-828X.2010.01274.x","article-title":"Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome\u2013A meta-analysis of randomised trials","volume":"51","author":"Johnson","year":"2011","journal-title":"Aust. New Zeal. J. Obstet. Gynaecol."},{"key":"10.1016\/j.cca.2022.06.019_b0590","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1749-6632.2010.05679.x","article-title":"Metformin in polycystic ovary syndrome","volume":"1205","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2022.06.019_b0595","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-011-0705-5","article-title":"Microparticles and microRNAs: new players in the complex field of coagulation","volume":"8","author":"Camaioni","year":"2013","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0600","first-page":"e140","article-title":"The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases","volume":"26","author":"Puddu","year":"2010","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cca.2022.06.019_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172984","article-title":"An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis","volume":"872","author":"Markowicz-Piasecka","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cca.2022.06.019_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep36222","article-title":"Metformin uniquely prevents thrombosis by inhibiting platelet activation and mtDNA release","volume":"6","author":"Xin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2022.06.019_b0615","doi-asserted-by":"crossref","first-page":"702","DOI":"10.26502\/fccm.92920164","article-title":"Pleiotropic Antithrombotic Effects of Cardiovascular Drugs","volume":"4","author":"von Ehr","year":"2020","journal-title":"Cardiol. Cardiovasc. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0620","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1530\/EC-20-0173","article-title":"The effects of empagliflozin vs metformin on endothelial microparticles in overweight\/obese women with polycystic ovary syndrome","volume":"9","author":"Javed","year":"2020","journal-title":"Endocr Connect."},{"key":"10.1016\/j.cca.2022.06.019_b0625","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s40279-019-01133-6","article-title":"Exercise recommendations for women with polycystic ovary syndrome: is the evidence enough?","volume":"49","author":"Stepto","year":"2019","journal-title":"Sport. Med."},{"key":"10.1016\/j.cca.2022.06.019_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115860","article-title":"Differential impact of acute high-intensity exercise on circulating endothelial microparticles and insulin resistance between overweight\/obese males and females","volume":"10","author":"Durrer","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2022.06.019_b0635","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41366-019-0460-7","article-title":"Effects of an acute bout of exercise on circulating extracellular vesicles: tissue-, sex-, and BMI-related differences","volume":"44","author":"Rigamonti","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cca.2022.06.019_b0640","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fendo.2019.00200","article-title":"Circulating endothelial microparticles reduce in concentration following an exercise programme in women with polycystic ovary syndrome","volume":"10","author":"Kirk","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2022.06.019_b0645","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.3390\/app10144871","article-title":"Effect of physical exercise on the release of microparticles with angiogenic potential","volume":"10","author":"Di Credico","year":"2020","journal-title":"Appl. Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:05:10Z","timestamp":1757862310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122012098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":129,"alternative-id":["S0009898122012098"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microparticles as indicators of cardiometabolic risk in PCOS","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}